期刊文献+

Mouse models in liver cancer research:A review of current literature 被引量:16

Mouse models in liver cancer research:A review of current literature
下载PDF
导出
摘要 Primary liver cancer remains one of the most lethal malignancies worldwide. Due to differences in prevalence of etiological factors the incidence of primary liver can-cer varies among the world, with a peak in East-Asia. As this disease is still lethal in most of the cases, research has to be done to improve our understanding of the disease, offering insights for possible treatment options. For this purpose, animal models are widely used, especially mouse models. In this review, we describe the different types of mouse models used in liver cancer research, with emphasis on genetically engineered mice used in this field. We focus on hepatocellular carcinoma (HCC), as this is by far the most common type of primary liver cancer, accounting for 70%-85% of cases. Primary liver cancer remains one of the most lethal malignancies worldwide. Due to differences in prevalence of etiological factors the incidence of primary liver cancer varies among the world, with a peak in East-Asia. As this disease is still lethal in most of the cases, research has to be done to improve our understanding of the disease, offering insights for possible treatment options. For this purpose, animal models are widely used, especially mouse models. In this review, we describe the different types of mouse models used in liver cancer research, with emphasis on genetically engineered mice used in this field. We focus on hepatocellular carcinoma (HCC), as this is by far the most common type of primary liver cancer, accounting for 70%-85% of cases.
机构地区 Department of Surgery
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第45期6915-6923,共9页 世界胃肠病学杂志(英文版)
关键词 肝癌 癌细胞 治疗 临床 Primary liver cancer Hepatocellular carcinoma Mouse model Genetically engineered mice
  • 相关文献

参考文献2

二级参考文献12

  • 1Majumder M,Steele R,Ghosh AK,Zhou XY,Thornburg L,Ray R,Phillips NJ,Ray RB.Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice[].FEBS Letters.2003
  • 2Petersen J,Dandri M,Gupta S,Rogler CE.Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma[].Proceedings of the National Academy of Sciences of the United States of America.1998
  • 3Korenaga M,Wang T,Li Y,Showalter LA,Chan T,Sun J,Weinman SA.Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production[].Journal of Biological Chemistry.2005
  • 4Majumder M,Ghosh AK,Steele R,Zhou XY,Phillips NJ,Ray R,Ray RB.Hepatitis C virus NS5A protein impairs TNF- mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice[].Journal of Virology.2002
  • 5Choo QL,Kuo G,Weiner AJ,Overby LR,Bradley DW,Houghton M.Isolation of a cDNA clone derived from a blood- borne non-A, non-B viral hepatitis genome[].Science.1989
  • 6Duong FH,Filipowicz M,Tripodi M,La Monica N,Heim MH.Hepatitis C virus inhibits interferon signaling through up- regulation of protein phosphatase 2A[].Gastroenterology.2004
  • 7Koike K.Hepatitis C virus infection can present with metabolic disease by inducing insulin resistance[].Intervirology.2006
  • 8Soguero C,Joo M,Chianese-Bullock KA,Nguyen DT,TungK,Hahn YS.Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model[].Journal of Virology.2002
  • 9Yoshida T,Hanada T,Tokuhisa T,Kosai K,Sata M,Kohara M,Yoshimura A.Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation[].The Journal of Experimental Medicine.2002
  • 10Sarcar B,Ghosh AK,Steele R,Ray R,Ray RB.Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase[].Journal of Virology.2004

共引文献41

同被引文献123

引证文献16

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部